156 related articles for article (PubMed ID: 30894322)
1. Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes.
He Z; Hu Y; Gui Z; Zhou Y; Nie T; Zhu J; Liu Z; Chen K; Liu L; Leong KW; Cao P; Chen Y; Mao HQ
J Control Release; 2019 May; 301():119-128. PubMed ID: 30894322
[TBL] [Abstract][Full Text] [Related]
2. A polyphenol-metal nanoparticle platform for tunable release of liraglutide to improve blood glycemic control and reduce cardiovascular complications in a mouse model of type II diabetes.
He Z; Nie T; Hu Y; Zhou Y; Zhu J; Liu Z; Liu L; Leong KW; Chen Y; Mao HQ
J Control Release; 2020 Feb; 318():86-97. PubMed ID: 31838207
[TBL] [Abstract][Full Text] [Related]
3. Prolonged melittin release from polyelectrolyte-based nanocomplexes decreases acute toxicity and improves blood glycemic control in a mouse model of type II diabetes.
Gui Z; Zhu J; Ye S; Ye J; Chen J; Ling Y; Cai X; Cao P; He Z; Hu C
Int J Pharm; 2020 Mar; 577():119071. PubMed ID: 31991184
[TBL] [Abstract][Full Text] [Related]
4. Kinetic control of Phytic acid/Lixisenatide/Fe (III) ternary nanoparticles assembly process for sustained peptide release.
Wang Y; Song X; Zhuang L; Lang H; Yu L; Yan X; He Z
Int J Pharm; 2022 Jan; 611():121317. PubMed ID: 34838624
[TBL] [Abstract][Full Text] [Related]
5. Long-Acting Release Formulation of Exendin-4 Based on Biomimetic Mineralization for Type 2 Diabetes Therapy.
Chen W; Wang G; Yung BC; Liu G; Qian Z; Chen X
ACS Nano; 2017 May; 11(5):5062-5069. PubMed ID: 28437610
[TBL] [Abstract][Full Text] [Related]
6. Sol-gel transition of nanoparticles/polymer mixtures for sustained delivery of exenatide to treat type 2 diabetes mellitus.
Oh KS; Kim JY; Yoon BD; Lee M; Kim H; Kim M; Seo JH; Yuk SH
Eur J Pharm Biopharm; 2014 Nov; 88(3):664-9. PubMed ID: 25152212
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo sustained release of exenatide from vesicular phospholipid gels for type II diabetes.
Zhang Y; Zhong Y; Hu M; Xiang N; Fu Y; Gong T; Zhang Z
Drug Dev Ind Pharm; 2016; 42(7):1042-9. PubMed ID: 26558908
[TBL] [Abstract][Full Text] [Related]
8. BÜCHI nano spray dryer B-90: a promising technology for the production of metformin hydrochloride-loaded alginate-gelatin nanoparticles.
Shehata TM; Ibrahima MM
Drug Dev Ind Pharm; 2019 Dec; 45(12):1907-1914. PubMed ID: 31621436
[TBL] [Abstract][Full Text] [Related]
9. Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats.
Shi S; Song S; Liu X; Zhao G; Ding F; Zhao W; Zhang S; Song Y; Ma W
Drug Deliv; 2022 Dec; 29(1):548-560. PubMed ID: 35156499
[TBL] [Abstract][Full Text] [Related]
10. Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation.
Chen C; Zheng H; Xu J; Shi X; Li F; Wang X
Daru; 2017 Sep; 25(1):20. PubMed ID: 28870261
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
Devarajan PV; Sonavane GS
Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
[TBL] [Abstract][Full Text] [Related]
12. Prolonged activity of exenatide: Detailed comparison of Site-specific linear polyglycerol- and poly(ethylene glycol)-conjugates.
Tully M; Wedepohl S; Kutifa D; Weise C; Licha K; Schirner M; Haag R
Eur J Pharm Biopharm; 2021 Jul; 164():105-113. PubMed ID: 33957224
[TBL] [Abstract][Full Text] [Related]
13. Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model.
Suzuki K; Kim KS; Bae YH
J Control Release; 2019 Jan; 294():259-267. PubMed ID: 30572033
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of palmitic acid-conjugated exendin-4 with delayed absorption and prolonged circulation for longer hypoglycemia.
Lee J; Lee C; Kim I; Moon HR; Kim TH; Oh KT; Lee ES; Lee KC; Youn YS
Int J Pharm; 2012 Mar; 424(1-2):50-7. PubMed ID: 22226877
[TBL] [Abstract][Full Text] [Related]
15. A pH-Triggered Self-Unpacking Capsule Containing Zwitterionic Hydrogel-Coated MOF Nanoparticles for Efficient Oral Exendin-4 Delivery.
Zhou Y; Chen Z; Zhao D; Li D; He C; Chen X
Adv Mater; 2021 Aug; 33(32):e2102044. PubMed ID: 34216408
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice.
Bao X; Qian K; Yao P
J Nanobiotechnology; 2020 Apr; 18(1):67. PubMed ID: 32345323
[TBL] [Abstract][Full Text] [Related]
17. Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects.
Son S; Lim SM; Chae SY; Kim K; Park EJ; Lee KC; Na DH
Int J Pharm; 2015 Nov; 495(1):81-86. PubMed ID: 26325318
[TBL] [Abstract][Full Text] [Related]
18. Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres.
Li T; Chandrashekar A; Beig A; Walker J; Hong JKY; Benet A; Kang J; Ackermann R; Wang Y; Qin B; Schwendeman AS; Schwendeman SP
Eur J Pharm Biopharm; 2021 Jan; 158():401-409. PubMed ID: 33122118
[TBL] [Abstract][Full Text] [Related]
19. Sustained Release of Exendin 4 Using Injectable and Ionic-Nano-Complex Forming Polymer Hydrogel System for Long-Term Treatment of Type 2 Diabetes Mellitus.
Seo BB; Park MR; Song SC
ACS Appl Mater Interfaces; 2019 May; 11(17):15201-15211. PubMed ID: 30945843
[TBL] [Abstract][Full Text] [Related]
20. Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug release.
Kumar S; Bhanjana G; Verma RK; Dhingra D; Dilbaghi N; Kim KH
J Pharm Pharmacol; 2017 Feb; 69(2):143-150. PubMed ID: 28033667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
